1) investigational new drug
创新性药品
1.
We systemically analyzed supplement submission of application for investigational new drugs,which send from the Agency to companies.
通过对创新性化学药品在注册申请过程中向企业发出补充通知要求补充资料的情况进行系统性分析,探求影响创新性药品技术审评效率的制约因素。
2.
Through the systematical analysis in chemical investigational new drug(IND) applications from 2005 to 2008,the current situation of IND applications is confirmed.
通过对2005～2008年期间在我国申报的创新性化学药品的申请情况进行系统性分析,明确目前我国创新性药品研发和申报的现状。
3) new medicinal products
创新性药物
1.
Guidance for the evaluation and design of clinical trials of new medicinal products in treatment of chronic hepatitis B;
治疗慢性乙型肝炎创新性药物的临床试验设计及关注要点
4) The independent innovation drugs
自主创新药品
1.
The independent innovation drugs are not only enterprise's important part, more importa.
虽然现有的自主创新药品所占比重较小，但其已成为大势所趋。
5) creativity of product
产品创新性
1.
The process of float a new product to market involves advertising, across to the different of the content, and advertisement can divide into two kinds: rational advertisement and emotional advertisement, they have different influence on customer perception of the creativity of product, the diversity may affect cust.
随着产品创新成为企业间竞争的重要手段,消费者对产品创新性的感知成为消费者对产品整体价值评价的重要组成部分。
6) new anti-bacterial drugs
创新性抗菌药物
补充资料：非法提供麻醉药品、精神药品罪
非法提供麻醉药品、精神药品罪：指依法从事生产、运输、管理、使用国家管制的麻醉药品、精神药品的单位和个人，明知他人是吸毒者，而向其提供国家管制的能够使人成瘾的麻醉药品、精神药品的行为。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条